PF-07275315 / Pfizer - LARVOL DELTA

A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: Pfizer

New P1 trial

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis (clinicaltrials.gov) - P2 | N=340 | Recruiting | Sponsor: Pfizer | Trial completion date: Feb 2026 ➔ Sep 2026 | Trial primary completion date: Sep 2025 ➔ Mar 2026

Trial completion date • Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis (clinicaltrials.gov) - P2 | N=340 | Recruiting | Sponsor: Pfizer | Trial primary completion date: Feb 2026 ➔ Sep 2025

Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People (clinicaltrials.gov) - P1 | N=65 | Completed | Sponsor: Pfizer | Active, not recruiting ➔ Completed

Trial completion

A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People (clinicaltrials.gov) - P1 | N=65 | Active, not recruiting | Sponsor: Pfizer | N=36 ➔ 65 | Trial completion date: Dec 2024 ➔ Jun 2024 | Trial primary completion date: Dec 2024 ➔ Jun 2024

Enrollment change • Trial completion date • Trial primary completion date

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis (clinicaltrials.gov) - P2 | N=340 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting

Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis (clinicaltrials.gov) - P2 | N=340 | Not yet recruiting | Sponsor: Pfizer

New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People (clinicaltrials.gov) - P1 | N=36 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting | N=89 ➔ 36

Enrollment change • Enrollment closed • Solid Tumor